SVP Global Molecular Architects, Evotec
David's career has been dedicated to applying early stage in silico technologies and data science to drive drug discovery research forward, with a primary aim of increasing the likelihood of achieving clinical success for patients. His expertise lies in harnessing computational tools and data-driven approaches to expedite the drug development process, optimizing its efficiency and efficacy. By leveraging cutting-edge in silico methodologies, David endeavours to bridge the gap between research and tangible patient outcomes, ultimately bringing novel and promising treatments to those in need with greater precision and success.
Got a Question for David Pardoe?
Get in touch using the contact form linked here and we’ll get back to you shortly
